The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued development and standardization of methodologies for biomarkers and has provided an increased depth and breadth of data available to qualified researchers. This review summarizes the over 400 publications using ADNI data during 2014 and 2015. Taken together, these studies fundamentally deepen the understanding of AD progression and its underlying genetic basis, which in turn informs and improves clinical trial design.
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
NCJ Number
255271
Journal
Alzheimers & Dementia Volume: 13 Issue: 4 Dated: 2017 Pages: E1-E85
Date Published
2017
Length
85 pages
Annotation
This Alzheimer's Disease Neuroimaging Initiative (ADNI) review summarizes approximately 400 publications, using ADNI data during 2014 and 2015.
Abstract